These results, in combination of the decreased expression of TLR4 at late stages of tumor growth (10 days after tumor inoculation) reported previously19, indicates that BLS can interact with the tumor cells in vivo through TLR4, inducing an antitumoral response. This evidence concerns the gene TLR4 and neoplasm.